Evoke Spinal Cord Stimulation (SCS) System

DEVICE5 trials

Sponsors

Saluda Medical Pty Ltd

Conditions

Back PainChronic PainPain

Unknown Phase

ECAP-controlled, Closed-loop Stimulation to Treat Chronic Trunk and/or Limb Pain (ECAP)

CompletedNCT04319887

Saluda Medical Pty LtdBack Pain, Chronic Pain, Pain

Start: 2020-10-29End: 2023-12-28Updated: 2024-12-31

Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs

Active, not recruitingNCT04627974

Saluda Medical Pty LtdChronic Pain

Start: 2020-08-05End: 2028-12-31Updated: 2026-05-15

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

RecruitingNCT04662905

Saluda Medical Pty LtdChronic Pain

Start: 2020-12-15End: 2027-01-01Target: 200Updated: 2026-05-19

Evoke Data Collection Study Germany

CompletedNCT05272137

Saluda Medical Pty LtdChronic Pain

Start: 2022-02-04End: 2022-10-17Updated: 2023-04-12

Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain

Active, not recruitingNCT06229470

Saluda Medical Pty LtdChronic Pain

Start: 2024-03-08End: 2027-02-28Updated: 2026-08-27

Related Papers

Objective, Same-Day SCS Trials with ECAP-Controlled Closed-Loop Therapy: Depth of Response is Maintained from Trial to 12 months.

2026-03-03

Next-Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience.

2026-01-08

Identifying SCS Trial Responders Immediately After Postoperative Programming with ECAP Dose-Controlled Closed-Loop Therapy.

2024-07-094 citations

Durability of Evoked Compound Action Potential (ECAP)-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) in a Real-World European Chronic Pain Population

Pain and Therapy2024-07-0211 citations